Moody T E, Vaughan E D, Wyker A T, Gillenwater J Y
Invest Urol. 1977 Mar;14(5):390-7.
Intrarenal infusion of Sar1-Ala8 angiotensin II(P113), a competitive antagonist of angiotensin II, failed to reverse or prevent the decreased ipsilateral renal blood flow and increased renal resistance characteristic of chronic unilateral ureteral occlusion and did not significantly alter plasma renin activity in the chronic state. Thus, angiotensin II does not appear to play a significant role in the hemodynamic response to unilateral ureteral occlusion.
肾内输注血管紧张素II的竞争性拮抗剂Sar1-Ala8血管紧张素II(P113),未能逆转或预防慢性单侧输尿管梗阻所特有的同侧肾血流量减少和肾阻力增加,并且在慢性状态下未显著改变血浆肾素活性。因此,血管紧张素II似乎在单侧输尿管梗阻的血流动力学反应中不起重要作用。